CN108220414A - ApoE genetic tests primer sets, detection kit and detection method - Google Patents

ApoE genetic tests primer sets, detection kit and detection method Download PDF

Info

Publication number
CN108220414A
CN108220414A CN201611136848.2A CN201611136848A CN108220414A CN 108220414 A CN108220414 A CN 108220414A CN 201611136848 A CN201611136848 A CN 201611136848A CN 108220414 A CN108220414 A CN 108220414A
Authority
CN
China
Prior art keywords
seq
apoe
primers
sequence
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611136848.2A
Other languages
Chinese (zh)
Inventor
盛司潼
黄思强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHEN HYK GENE TECHNOLOGY Co Ltd
Original Assignee
SHENZHEN HYK GENE TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN HYK GENE TECHNOLOGY Co Ltd filed Critical SHENZHEN HYK GENE TECHNOLOGY Co Ltd
Priority to CN201611136848.2A priority Critical patent/CN108220414A/en
Publication of CN108220414A publication Critical patent/CN108220414A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to genetic engineering and biology field, a kind of ApoE genetic tests primer sets, including at least one of rs429358 primer sets and rs7412 primer sets, the rs429358 primer sets are used to expand the nucleic acid fragment in the site containing rs429358;The rs7412 primer sets are used to expand the nucleic acid fragment in the site containing rs7412.The present invention also provides a kind of ApoE gene detecting kits and detection methods.ApoE genetic tests primer sets using the present invention expand the nucleic acid fragment containing site to be measured, reduce the possibility for expanding multiple target sites, improve the specificity expanded to the nucleic acid fragment containing site to be measured and sensitivity, reduce false positive rate;Meanwhile using second generation high throughput gene sequencing technology so that the detection cycle for treating location point is short, and flux is high.

Description

ApoE genetic tests primer sets, detection kit and detection method
Technical field
The present invention relates to genetic engineering and biology field, more specifically to a kind of ApoE gene primers group, Detection kit and detection method.
Background technology
ApoE genes and a variety of cardiovascular and cerebrovascular diseases are closely related, the apo E of coding(Apolipoprotein E, ApoE)Participate in the entire occurrence and development process of the cardiovascular and cerebrovascular diseases such as hyperlipemia, atherosclerosis, coronary heart disease, ApoE The main reason for gene pleiomorphism is individual difference in these diseases early stage and evolution.
ApoE genetic models are proposed according to ApoE phenotypes, it is believed that the synthesis of ApoE is by being located at three on a gene loci A allele is controlled, i.e. E2, E3 and E4, each allele corresponds to a main isomer and generates three kinds of homozygotes (E2/2, E3/3, E4/4) and three kinds of heterozygotes (E2/3, E2/4, E3/4) totally six kinds of common phenotypics.ApoE3/3 types are also known as wild Type.ApoE is a polymorphism albumen, and there are three common isomers, i.e. E2, E3 and E4.The 112 of the amino acid sequence of ApoE Position(Cys112Arg, rs429358, hereinafter referred to as 358)With 158(Arg158Cys, rs7412, hereinafter referred to as 412)Two kinds of ammonia Base acid residue, that is, arginine(Arg)And cysteine(Cys)Exchange determine the type of isomers.ApoE4 is in the two positions Put all is Arg;E2 is Cys;It is Arg person is ApoE3 isomers that 112, which are Cys and 158,.In general population, gene frequency Rate E3 is distributed highest, ApoE3/3 Phenotype Distributions about 70%.
In addition both at home and abroad it is multinomial the study found that ApoE genes be the Alzheimer disease being currently known it is most close heredity mark Will object, the neurological susceptibility of ApoE4 carrier's Alzheimer diseases increase.After ApoE mutation, change with the affinity of LDL-R Become.Individual its for carrying an E4 allele develops into individual about 3-4 times of the possibility of AD higher than no E4 allele.E4 Allele ratio in general population is about 15%, and the ratio in AD patient is up to 40%.ApoE4 is the important danger of AD Dangerous factor.By the genotype for detecting ApoE, it may be appreciated that whether be AD Susceptible population, then from teiology delay AD generation, Development;And inspect periodically, so as to early diagnosis, to the greatest extent early treatment, damage caused by reduction disease.
Be detected by the ApoE genes to patient, obtain the genotype of specific site, using genetic test result as The method of the information of intermediate result is not belonging to the diagnostic method of disease;The selection of drug is determined with the testing result of genotype, It can realize personalized medicine, avoid to immunosuppressor adverse reaction.
At present to the detection of gene mutation and gene pleiomorphism, it is common have direct sequencing, gene chip hybridization method, Taqman fluorescence probe method, allele specific amplification method(Amplification Refractory Mutation System Real Time PCR, ARMS-RT PCR), allele specific amplification method(Amplification Refractory Mutation System Real Time PCR, ARMS-RT PCR)Deng.Above method sensitivity is low, false sun Property rate is high, it is longer to take, flux is small.
Therefore, it is necessary to a kind of kits and detection method of new detection ApoE gene mutation so as to ApoE bases Because of the high sensitivity of mutation, false positive rate is low, and detection cycle is short.
Invention content
The purpose of the present invention is to provide a kind of ApoE gene detecting kits and detection methods, it is intended to solve the prior art The technical issues of middle ApoE genetic tests sensitivity is low, false positive rate is high, the period is long, and flux is small.
The present invention provides a kind of ApoE genetic tests primer sets, a kind of ApoE genetic tests primer sets, including At least one of rs429358 primer sets and rs7412 primer sets;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets are for expanding the nucleic acid fragment in the site containing rs7412, including rs7412 sense primers and rs7412 Downstream primer, the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, the rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence.
Preferably, the rs429358 primer sets include ApoE primer sets and rs429358 inner primer groups;The rs7412 Primer sets include ApoE primer sets and rs7412 inner primer groups;The ApoE primer sets are described for expanding ApoE genetic fragments Rs429358 inner primers group is used to expand the ApoE genetic fragments in the site containing rs429358;The rs7412 inner primers group is used to expand Increase the ApoE genetic fragments in the site containing rs7412.
The present invention also provides a kind of ApoE gene detecting kits, the ApoE gene detecting kits include above-mentioned A kind of ApoE genetic tests primer sets.
Preferably, the ApoE gene detecting kits further include connector, and sequence label is contained on the connector, described to connect Amplified production of the head for directly with site containing rs429358 and/or rs7412 sites is connect.
Preferably, the ApoE gene detecting kits further include rs429358 sequencing primers and/or rs7412 sequencings are drawn Object, the rs429358 sequencing primers have SEQ ID NO:29、SEQ ID NO:30、SEQ ID NO:31、SEQ ID NO: 32、SEQ ID NO:33、SEQ ID NO:34 or SEQ ID NO:35 sequence;The rs7412 sequencing primers have SEQ ID NO:36、SEQ ID NO:37 or SEQ ID NO:38 sequence.
Preferably, the ApoE gene detecting kits further include the oligonucleotide probe of unstressed configuration label.
The present invention also provides a kind of ApoE gene testers, include the following steps:
A, using rs429358 primer sets, the nucleic acid fragment in the site containing rs429358 is expanded, obtains rs429358 amplification productions Object;Or rs7412 primer sets are utilized, the nucleic acid fragment in the site containing rs7412 is expanded, obtains rs7412 amplified productions;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets include rs7412 sense primers and rs7412 downstream primers, and the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, it is described Rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence;
B, the jointing on the rs429358 amplified productions and/or rs7412 amplified productions obtains rs429358 libraries point Son and/or rs7412 library molecules;
C, the library molecule is sequenced using second generation high throughput gene sequencing technology, determine rs429358 and/or The genotype in rs7412 sites.
Preferably, the step A includes the following steps:
A1, ApoE genetic fragments are expanded using ApoE primer sets, obtains the first amplified production, the ApoE primer sets are included on ApoE Primer and ApoE downstream primers are swum, the ApoE sense primers have SEQ ID NO:1 or SEQ ID NO:2 sequence, it is described ApoE downstream primers have SEQ ID NO:12 or SEQ ID NO:13 sequence;
A2, using the first amplified production as template, using rs429358 inner primers group amplification the site containing rs429358 ApoE genes Segment, obtains the 2nd rs429358 amplified productions, the rs429358 inner primers group include in rs429358 sense primer and Downstream primer in rs429358, sense primer has SEQ ID NO in the rs429358:3、SEQ ID NO:4、SEQ ID NO:5 or SEQ ID NO:6 sequence, downstream primer has SEQ ID NO in the rs429358:14 or SEQ ID NO:15 Sequence;Or sense primer has SEQ ID NO in the rs429358:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:Downstream primer has SEQ ID NO in 11, the rs429358:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;Using the ApoE genetic fragments in rs7412 inner primers group amplification site containing rs7412, the 2nd rs7412 is obtained Amplified production, the rs7412 inner primers group include downstream primer in sense primer in rs7412 and rs7412, the rs7412 Interior sense primer has SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, downstream in the rs7412 Primer has SEQ ID NO:22 sequence.
Preferably, the step B includes the following steps:
B1, the jointing on the 2nd rs429358 amplified productions and/or the 2nd rs7412 amplified productions, obtain Rs429358 library molecules and/or rs7412 library molecules;
B2, by the biotin labeling on connector, the rs429358 library molecules and/or rs7412 library molecules are fixed on On magnetic bead containing Avidin;It is fixed on magnetic bead is addressable on solid phase carrier.
Preferably, rs429358 sequencing primers and/or rs7412 sequencing primers are used in step C to the text containing site to be measured Library molecule is sequenced, and the rs429358 sequencing primers have SEQ ID NO:29、SEQ ID NO:30、SEQ ID NO: 31、SEQ ID NO:32、SEQ ID NO:33、SEQ ID NO:34 or SEQ ID NO:35 sequence;The rs7412 sequencings Primer has SEQ ID NO:36、SEQ ID NO:37 or SEQ ID NO:38 sequence.
The nucleic acid fragment containing site to be measured is expanded using ApoE genetic tests primer sets provided by the invention, reduces amplification The possibility of multiple target sites improves the specificity expanded to the nucleic acid fragment containing site to be measured and sensitivity, reduces vacation Positive rate;Meanwhile using second generation high throughput gene sequencing technology so that the detection cycle for treating location point is short, and flux is high.
Specific embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiments, to the present invention It is further elaborated.
The present invention proposes first embodiment, a kind of ApoE genetic tests primer sets, including rs429358 primer sets and At least one of rs7412 primer sets;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets are for expanding the nucleic acid fragment in the site containing rs7412, including rs7412 sense primers and rs7412 Downstream primer, the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, the rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence.
This programme provide ApoE genetic test primer sets, can specific amplification site containing rs429358 and/or The nucleic acid fragment of rs7412 reduces the possibility for expanding non-target fragment so as to rs429358 sites and/or The high sensitivity of rs7412 site primers, false positive rate are low.
Preferably, the rs429358 primer sets include ApoE primer sets and rs429358 inner primer groups;The rs7412 Primer sets include ApoE primer sets and rs7412 inner primer groups;The ApoE primer sets are described for expanding ApoE genetic fragments Rs429358 inner primers group is used to expand the ApoE genetic fragments in the site containing rs429358;The rs7412 inner primers group is used to expand Increase the ApoE genetic fragments in the site containing rs7412.
The ApoE primer sets include ApoE sense primers and ApoE downstream primers;The ApoE sense primers have SEQ ID NO:1 or SEQ ID NO:2 sequence, the ApoE downstream primers have SEQ ID NO:12 or SEQ ID NO:13 sequence Row.
The rs429358 inner primers group includes downstream primer in sense primer in rs429358 and rs429358;It is described Sense primer has SEQ ID NO in rs429358:3、SEQ ID NO:4、SEQ ID NO:5 or SEQ ID NO:6 sequence, Downstream primer has SEQ ID NO in the rs429358:14 or SEQ ID NO:15 sequence;Or the rs429358 on Swimming primer has SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence It arranges, downstream primer has SEQ ID NO in the rs429358:16、SEQ ID NO:17 or SEQ ID NO:18 sequence.
The rs7412 inner primers group includes downstream primer in sense primer in rs7412 and rs7412;In the rs7412 Sense primer has SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, downstream is drawn in the rs7412 Object has SEQ ID NO:22 sequence.
The two groups of ApoE genetic test primer sets provided using this programme are treated location point and carry out two-wheeled nested amplification, due to The sequence all complementary with two groups of primer sets is seldom simultaneously, so as to reduce the possibility of non-specific amplification, increases to be measured The susceptibility of site primer.In the present solution, SEQ ID NO:3、SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:16、SEQ ID NO:17、SEQ ID NO:18、SEQ ID NO:19、SEQ ID NO:20、SEQ ID NO:On 21 Comprising ACCU sequences, the nucleic acid fragment containing site to be measured is expanded using the ApoE gene primers group of this programme, is obtained Comprising ACCU sequences on amplified production, amplified production is cut using the enzyme of specificity cutting uracil, viscosity can be formed End, cohesive end joint efficiency higher during follow-up jointing.
The present invention proposes second embodiment, and a kind of ApoE gene detecting kits are examined containing any of the above-described kind of ApoE gene Survey primer sets.
The kit of the present invention is capable of the nucleic acid fragment of specific amplification site containing rs429358 and/or rs7412, reduces The possibility of the non-target fragment of amplification, so as to the high sensitivity in rs429358 sites and/or rs7412 site primers, False positive rate is low.
Location point is treated using two groups of ApoE genetic test primer sets and carries out two-wheeled nested amplification, due to drawing simultaneously with two groups The all complementary sequence of object group is seldom, so as to reduce the possibility of non-specific amplification, increases to treat and surveys the quick of site primer Sensitivity.
Preferably, the kit further includes the oligonucleotide probe of unstressed configuration label.
It should be noted that the oligonucleotide probe of the unstressed configuration label and the fluorescence connecting used in sequencing technologies Probe is compared, and sequence is identical, differs only in unstressed configuration label.The kit of this programme, adds in nothing in sequencing procedure The oligonucleotide probe of fluorescent marker can effectively reduce the error signal occurred in connection sequencing, improve and treat location point The accuracy of detection.
Preferably, the kit further includes the enzyme of specificity cutting uracil, the enzyme of the specificity cutting uracil For USER enzymes, RNase H or UDG enzymes.
Due to the SEQ ID NO of the second wheel amplification:3、SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:16、SEQ ID NO:17、SEQ ID NO:18、SEQ ID NO:19、SEQ ID NO:20、SEQ ID NO:21 sequences On comprising ACCU sequences, therefore also comprising ACCU sequences on obtained amplified production, using the enzyme of specificity cutting uracil Amplified production is cut, forms cohesive end, cohesive end joint efficiency higher during follow-up jointing.
Preferably, the kit further includes connector, contains sequence label on the connector, the connector for directly with The amplified production in the site containing rs429358 and/or rs7412 sites connects.
It should be noted that kit provided by the invention, is carried out separately the amplification step in different sites to be measured, Multiple amplified productions containing different sites to be measured may be mixed together and be carried out at the same time sequencing.When kit using the present invention When being carried out at the same time detection to the rs429358 sites of same sample and rs7412 sites in same system, and containing rs429358 The connector of the amplified production connection of point and the connector that is connect with the amplified production in the site containing rs7412, sequence label thereon can be with It is identical, it can also be different.When the sequence label difference on connector, can be treated by the detection of butt joint sequence label to distinguish The genotype of location point when the sequence label on connector is identical, can be distinguished by the difference of used sequencing primer The genotype in site to be measured.
When kit using the present invention is to simultaneously examining the same site to be measured of different samples in same system During survey, since the sequencing primer used in sequencing procedure is identical, it is therefore desirable to use the connector containing different sequence labels Different samples is connected respectively, by the way that sequence label is sequenced, can effectively be distinguished without carrying out repeatedly sequencing to sample The sequencing result of different samples.
Diversified forms may be used in the connector of the present invention, including but not limited to flat end fitting, protruding terminus connector, bifurcated Connector or the connector containing loop-stem structure.
Preferably, the connector is protruding terminus connector, and the protruding terminus is cut with the amplified production through specificity The cohesive end complete complementary pairing formed after the cleavage of uracil, this programme cause the connection between amplified production and connector It is more efficient.
Preferably, contain biotin labeling on the connector, for it to be made to be fixed on the magnetic bead containing Avidin.
It is furthermore preferred that the connector includes at least one of connector A, connector B, connector C, the connector A is by SEQ ID NO:23 and SEQ ID NO:The double-stranded nucleic acid molecule of 24 compositions;The connector B is by SEQ ID NO:25 and SEQ ID NO:The double-stranded nucleic acid molecule of 26 compositions;The connector C is by SEQ ID NO:27 and SEQ ID NO:The double-strandednucleic acid of 28 compositions Molecule;NNNN in the connector is sequence label, and the N is A, G, C or T.
Preferably, the kit further includes rs429358 sequencing primers and/or rs7412 sequencing primers, described Rs429358 sequencing primers have SEQ ID NO:29、SEQ ID NO:30、SEQ ID NO:31、SEQ ID NO:32、SEQ ID NO:33、SEQ ID NO:34 or SEQ ID NO:35 sequence;The rs7412 sequencing primers have SEQ ID NO:36、 SEQ ID NO:37 or SEQ ID NO:38 sequence.
It is furthermore preferred that on the sequencing primer for linking probe one end away from site to be measured be 1 to 9bp, more preferably 1 To 5bp.This programme causes in sequencing procedure, it is only necessary to carry out the genotype that primary connection sequencing can determine site to be measured.
Preferably, the kit further includes ligase.Under the action of ligase, between the amplified production and connector The connection that can stablize.
Preferably, the kit further includes connection buffer solution.
The present invention proposes 3rd embodiment, and a kind of ApoE gene testers include the following steps:
A, using rs429358 primer sets, the nucleic acid fragment in the site containing rs429358 is expanded, obtains rs429358 amplification productions Object;Or rs7412 primer sets are utilized, the nucleic acid fragment in the site containing rs7412 is expanded, obtains rs7412 amplified productions;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets include rs7412 sense primers and rs7412 downstream primers, and the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, it is described Rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence;
B, the jointing on the rs429358 amplified productions and/or rs7412 amplified productions obtains rs429358 libraries point Son and/or rs7412 library molecules;
C, the library molecule is sequenced using second generation high throughput gene sequencing technology, determine rs429358 and/or The genotype in rs7412 sites.
Preferably, the step A includes the following steps:
A1, ApoE genetic fragments are expanded using ApoE primer sets, obtains the first amplified production, the ApoE primer sets are included on ApoE Primer and ApoE downstream primers are swum, the ApoE sense primers have SEQ ID NO:1 or SEQ ID NO:2 sequence, it is described ApoE downstream primers have SEQ ID NO:12 or SEQ ID NO:13 sequence;
A2, using the first amplified production as template, using rs429358 inner primers group amplification the site containing rs429358 ApoE genes Segment, obtains the 2nd rs429358 amplified productions, the rs429358 inner primers group include in rs429358 sense primer and Downstream primer in rs429358, sense primer has SEQ ID NO in the rs429358:3、SEQ ID NO:4、SEQ ID NO:5 or SEQ ID NO:6 sequence, downstream primer has SEQ ID NO in the rs429358:14 or SEQ ID NO:15 Sequence;Or sense primer has SEQ ID NO in the rs429358:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:Downstream primer has SEQ ID NO in 11, the rs429358:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;Using the ApoE genetic fragments in rs7412 inner primers group amplification site containing rs7412, the 2nd rs7412 is obtained Amplified production, the rs7412 inner primers group include downstream primer in sense primer in rs7412 and rs7412, the rs7412 Interior sense primer has SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, downstream in the rs7412 Primer has SEQ ID NO:22 sequence.
This programme carries out two-wheeled specificity expansion by designing two pairs of amplimer groups, to the nucleic acid fragment containing site to be measured Increase, can effectively ensure the dirt of the non-specific amplification not caused by primer pairing specificity is not strong in the second amplified production Dye, reduces the possibility for expanding multiple target sites, increases specificity and the sensitivity of amplification.
Preferably, it is further included in the step B to the 2nd rs429358 amplified productions and/or the 2nd rs7412 amplified productions The step of middle enzyme for adding in specificity cutting uracil is cut, digestion of the amplified production through specificity cutting uracil Cut generation cohesive end.Due to SEQ ID NO:3、SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO: 16、SEQ ID NO:17、SEQ ID NO:18、SEQ ID NO:19、SEQ ID NO:20 and SEQ ID NO:It is wrapped on 21 Sequence containing ACCU, after obtaining the 2nd rs429358 amplified productions and/or the 2nd rs7412 amplified productions by amplification, specificity is cut Cut the di-phosphate ester between the 2nd rs429358 amplified productions of cleavage and/or the 2nd rs7412 amplified productions G and U of uracil Key, forms the cohesive end that phosphate group is contained in 5 ' ends, which is conducive to the jointing during subsequent reactions.
Preferably, the enzyme of the specificity cutting uracil is USER enzymes, RNase H or UDG enzymes.
Preferably, the step B includes the following steps:
B1, the jointing on the 2nd rs429358 amplified productions and/or the 2nd rs7412 amplified productions, obtain Rs429358 library molecules and/or rs7412 library molecules;
B2, by the biotin labeling on connector, the rs429358 library molecules and/or rs7412 library molecules are fixed on On magnetic bead containing Avidin;It is fixed on magnetic bead is addressable on solid phase carrier.
Preferably, contain sequence label on the connector, the connector for directly with the site containing rs429358 and/ Or the amplified production connection in rs7412 sites.
It should be noted that the detection method that this programme provides, the amplification step to different sites to be measured is to separate progress , multiple amplified productions containing different sites to be measured may be mixed together and be carried out at the same time sequencing.When right in same system When the rs429358 sites and rs7412 sites of same sample are carried out at the same time detection, connect with the amplified production in the site containing rs429358 The connector connect and the connector being connect with the amplified production in the site containing rs7412, sequence label thereon can be identical, can not also Together.When the sequence label difference on connector, the gene in site to be measured can be distinguished by the detection of butt joint sequence label Type when the sequence label on connector is identical, can distinguish the base in site to be measured by the difference of used sequencing primer Because of type.
When being detected simultaneously to the same site to be measured of different samples in same system, due in sequencing procedure The sequencing primer used is identical, it is therefore desirable to connect different samples respectively using the connector containing different sequence labels, lead to It crosses and sequence label is sequenced, the sequencing result of different samples can be effectively distinguished without carrying out repeatedly sequencing to sample.
Diversified forms may be used in the connector of the present invention, including but not limited to flat end fitting, protruding terminus connector, bifurcated Connector or the connector containing loop-stem structure.
Preferably, the connector is protruding terminus connector, and the protruding terminus is cut with the amplified production through specificity The cohesive end complete complementary pairing formed after the cleavage of uracil, this programme cause the connection between amplified production and connector It is more efficient.
It is furthermore preferred that the connector includes at least one of connector A, connector B, connector C, the connector A is by SEQ ID NO:23 and SEQ ID NO:The double-stranded nucleic acid molecule of 24 compositions;The connector B is by SEQ ID NO:25 and SEQ ID NO:The double-stranded nucleic acid molecule of 26 compositions;The connector C is by SEQ ID NO:27 and SEQ ID NO:The double-strandednucleic acid of 28 compositions Molecule;NNNN in the connector is sequence label, and the N is A, G, C or T.
Preferably, the step C includes the following steps:
C1, the oligonucleotide probe marked using unstressed configuration, carry out rs429358 library molecules and/or rs7412 library molecules Primary connection sequencing;
C2, sequencing is attached to rs429358 library molecules and/or rs7412 library molecules using fluorescence probe, determined The genotype in rs429358 and/or rs7412 sites.
It should be noted that the oligonucleotide probe of the unstressed configuration label and the fluorescence connecting used in sequencing technologies Probe is compared, and sequence is identical, differs only in unstressed configuration label.The detection method of this programme, adds in sequencing procedure The oligonucleotide probe of unstressed configuration label can effectively reduce the error signal occurred in connection sequencing, improve and treat location The accuracy of point detection.
Connection sequencing each time includes the following steps:Sequencing primer is anchored, and is rinsed(Remove the extra sequencing not being anchored Primer), linking probe, flushing(Remove excess probes, ligase etc.), adopt figure(Obtain position corresponding to fluorescent marker on probe Sequence information), denaturation elution connection product(To connect the anchoring of sequencing primer in sequencing reaction next time).In step C1 Connection sequencing reaction because use unstressed configuration mark oligonucleotide probe, therefore can without adopting figure step, with Experimental procedure is reduced, improves conventional efficient.
The present invention provides fourth embodiment, a kind of ApoE gene testers, using the poba gene group DNA of two people as Template detects the rs429358 sites in each template ApoE genetic fragments and rs7412 sites respectively.It establishes according to the following steps anti- Answer system:
A1, for above-mentioned two sample, it is each to prepare two amplification ApoE genetic fragments totally 4 reaction systems:The blood-based of 50ng Because of a group DNA;5U/μLde Ex Taq 0.25μL;2×long Taq Mix(Shenzhen HYK Gene Technology Co., Ltd. produces) 10μL;10 μM of 2 μ L of ApoE sense primers;10 μM of 2 μ L of ApoE downstream primers;Each 4 μ L of dNTP of 2.5mM;Add deionized water To 50 μ L;Mixing simultaneously centrifuges.Then centrifuge tube is placed in PCR instrument, response procedures is set:Continue 3 minutes under the conditions of 94 DEG C;94 It is for 15 seconds under the conditions of DEG C, it is for 20 seconds under the conditions of 57 DEG C, continue 45 seconds under the conditions of 72 DEG C, altogether 20 cycles;72 DEG C of conditions Under continue 3 minutes;After the completion of amplified reaction, the first amplified production is obtained.Wherein, ApoE sense primers group is SEQ ID NO:1, ApoE downstream primers are SEQ ID NO:12;
A2, using the first amplified production of above-mentioned two sample as template, each one amplification site containing rs429358 of configuration with The reaction system of the ApoE genetic fragments in rs7412 sites, the system in one rs429358 sites of amplified sample is amplification system 1, is expanded The system for increasing one rs7412 sites of sample is amplification system 2, and the system in two rs429358 sites of amplified sample is amplification system 3, The system in two rs7412 sites of amplified sample is amplification system 4, and reaction system component is as follows:The first amplified productions of 100ng;10μM Inner primer group totally 4 μ L;Each 4 μ L of dNTP of 2.5mM;5U/μLde Ex Taq 0.25μL;2×long Taq Mix(Shenzhen China Yin Kang Gene Tech. Company Limited produces)10μL;Add deionized water to 50 μ L;Mixing simultaneously centrifuges.Centrifuge tube is placed in PCR instrument In, response procedures are set:Continue 3 minutes under the conditions of 94 DEG C;It is for 15 seconds under the conditions of 94 DEG C, it is for 20 seconds under the conditions of 57 DEG C, 72 Continue 45 seconds under the conditions of DEG C, altogether 30 cycles;Continue 3 minutes under the conditions of 72 DEG C;After the completion of PCR reactions, the second amplification production is obtained Object.Wherein, it is SEQ ID NO for the inner primer group of amplification system 1 and system 3:3 and SEQ ID NO:14;For expanding body Be 2 and system 4 inner primer group be SEQ ID NO:19 and SEQ ID NO:22;
It after the completion of second expands, is detected through Page gel electrophoresis, contains target molecule in the second amplified production of two samples, And electrophoretogram is shown without miscellaneous band, band is single;Illustrate that required amplified production has successfully been obtained in second of amplification.
B1, for the second amplified production obtained in amplification system 1-4, prepare cutting-coupled reaction system 1-4 respectively: The 10 μ L of USER enzymes of second amplified production, 20 μ L, T4 ligase buffer solution, 8 μ L, T4 DNA ligase, 2 μ L, 1U/ μ L, 10 μM 2 μ L of connector;Add deionized water to 40 μ L;25 DEG C are reacted 20 minutes, are obtained connection product, that is, are treated sequencing library molecule;
B2, library molecule is combined respectively with the magnetic bead that Avidin is modified so that library molecule is fixed on magnetic bead surfaces. The load sample piece that above-mentioned product point sample to isothiocyano is modified(Slide), in 37 DEG C of fixed 1h, that is, complete to be fixed on magnetic bead Treat that the addressable of sequencing library molecule is fixed;
Wherein buffer solution for Tris containing 400mM, 100mM MgCl2,100mM DTT, 5mM ATP, the solution of pH value 7.8;
Connector is by SEQ ID NO:29 and SEQ ID NO:30 compositions.The label of the connector used in cutting-coupled reaction system 1 Sequence is AGTC;The sequence label of the connector used in cutting-coupled reaction system 2 is ACAC;Cutting-coupled reaction system 3 The sequence label of the middle connector used is CAGT;The sequence label of the connector used in cutting-coupled reaction system 4 is GCCG.
C, the high-throughput gene sequencer of Shenzhen HYK Gene Technology Co., Ltd. is used in this embodiment Pstar II A sequenators, and be sequenced using connection PCR sequencing PCR.In sequencing procedure, for rs429358 sites, used Sequencing primer be SEQ ID NO:29;For rs7412 sites, used sequencing primer is SEQ ID NO:36.Sequencing knot Fruit shows the genotype in the rs429358 sites of sample one as wild-type homozygote TT, the gene in the rs7412 sites of sample one Type is saltant type homozygote TT, and the genotype in the rs429358 sites of sample two is saltant type heterozygote TC;The gene of sample two Type is wild-type homozygote CC.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention All any modification, equivalent and improvement made within refreshing and principle etc., should all be included in the protection scope of the present invention.
SEQUENCE LISTING
<110>Guangzhou Kang Xin Rui Jiyin health Science and Technology Ltd.
<120>ApoE genetic tests primer sets, detection kit and detection method
<130>
<160> 38
<170> PatentIn version 3.3
<210> 1
<211> 21
<212> DNA
<213>Artificial sequence
<400> 1
aggcctacaa atcggaactg g 21
<210> 2
<211> 18
<212> DNA
<213>Artificial sequence
<400> 2
cactgtgcga caccctcc 18
<210> 3
<211> 21
<212> DNA
<213>Artificial sequence
<400> 3
accucggaca tggaggtcgt g 21
<210> 4
<211> 21
<212> DNA
<213>Artificial sequence
<400> 4
accucggaga tggacgacgt g 21
<210> 5
<211> 21
<212> DNA
<213>Artificial sequence
<400> 5
accucggaca tggaggacgt g 21
<210> 6
<211> 21
<212> DNA
<213>Artificial sequence
<400> 6
accucggata tggagtacgt g 21
<210> 7
<211> 17
<212> DNA
<213>Artificial sequence
<400> 7
cggacatgga ggacgtg 17
<210> 8
<211> 17
<212> DNA
<213>Artificial sequence
<400> 8
cggatatgga gtacgtg 17
<210> 9
<211> 17
<212> DNA
<213>Artificial sequence
<400> 9
cggacatgga ggtcgtg 17
<210> 10
<211> 15
<212> DNA
<213>Artificial sequence
<400> 10
cacggctgtc caagg 15
<210> 11
<211> 17
<212> DNA
<213>Artificial sequence
<400> 11
cggagatgga cgacgtg 17
<210> 12
<211> 20
<212> DNA
<213>Artificial sequence
<400> 12
ctcgaaccag ctcttgaggc 20
<210> 13
<211> 19
<212> DNA
<213>Artificial sequence
<400> 13
gctgcccatc tcctccatc 19
<210> 14
<211> 16
<212> DNA
<213>Artificial sequence
<400> 14
ggtactgcac caggcg 16
<210> 15
<211> 16
<212> DNA
<213>Artificial sequence
<400> 15
gtactgcacc aggcgg 16
<210> 16
<211> 18
<212> DNA
<213>Artificial sequence
<400> 16
accucaccag gcggcagc 18
<210> 17
<211> 18
<212> DNA
<213>Artificial sequence
<400> 17
accucaccag gcgaccgc 18
<210> 18
<211> 18
<212> DNA
<213>Artificial sequence
<400> 18
accucaccag gcagccgc 18
<210> 19
<211> 21
<212> DNA
<213>Artificial sequence
<400> 19
accuccgatg acccgcagaa g 21
<210> 20
<211> 21
<212> DNA
<213>Artificial sequence
<400> 20
accuccgatg acctgaagaa g 21
<210> 21
<211> 21
<212> DNA
<213>Artificial sequence
<400> 21
accuccgatg acctccagaa g 21
<210> 22
<211> 16
<212> DNA
<213>Artificial sequence
<400> 22
tggtacactg ccaggc 16
<210> 23
<211> 50
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (23)..(26)
<223> n is a, c, g, or t
<400> 23
cctccctgca gtctctatgg gcnnnnctgc tagtcgctga agtagtacct 50
<210> 24
<211> 41
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (20)..(23)
<223> n is a, c, g, or t
<400> 24
ctacttcagc gactagcagn nnngcccata gagactgcag g 41
<210> 25
<211> 50
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (23)..(26)
<223> n is a, c, g, or t
<400> 25
cctccctgca gtctctatgg gcnnnnctgc tagtcgctgt tgtgatacct 50
<210> 26
<211> 41
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (20)..(23)
<223> n is a, c, g, or t
<400> 26
tcacaacagc gactagcagn nnngcccata gagactgcag g 41
<210> 27
<211> 50
<212> DNA
<213>Artificial sequence
<400> 27
cctccctgca gtctctatgg gcagtcctac ttgtcgctgt tgtgatacct 50
<210> 28
<211> 41
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (20)..(23)
<223> n is a, c, g, or t
<400> 28
tcacaacagc gacaagtagn nnngcccata gagactgcag g 41
<210> 29
<211> 17
<212> DNA
<213>Artificial sequence
<400> 29
cacgacctcc atgtccg 17
<210> 30
<211> 17
<212> DNA
<213>Artificial sequence
<400> 30
cacgtcgtcc atctccg 17
<210> 31
<211> 17
<212> DNA
<213>Artificial sequence
<400> 31
cacgtcctcc atgtccg 17
<210> 32
<211> 17
<212> DNA
<213>Artificial sequence
<400> 32
cacgtactcc atatccg 17
<210> 33
<211> 14
<212> DNA
<213>Artificial sequence
<400> 33
gctgccgcct ggtg 14
<210> 34
<211> 14
<212> DNA
<213>Artificial sequence
<400> 34
gcggtcgcct ggtg 14
<210> 35
<211> 14
<212> DNA
<213>Artificial sequence
<400> 35
gcggctgcct ggtg 14
<210> 36
<211> 17
<212> DNA
<213>Artificial sequence
<400> 36
cttctgcggg tcatcgg 17
<210> 37
<211> 17
<212> DNA
<213>Artificial sequence
<400> 37
cttcttcagg tcatcgg 17
<210> 38
<211> 17
<212> DNA
<213>Artificial sequence
<400> 38
cttctggagg tcatcgg 17

Claims (10)

1. a kind of ApoE genetic tests primer sets, which is characterized in that including in rs429358 primer sets and rs7412 primer sets It is at least one;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets are for expanding the nucleic acid fragment in the site containing rs7412, including rs7412 sense primers and rs7412 Downstream primer, the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, the rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence.
2. ApoE genetic tests primer sets according to claim 1, which is characterized in that the rs429358 primer sets include ApoE primer sets and rs429358 inner primer groups;The rs7412 primer sets include ApoE primer sets and rs7412 inner primer groups; The ApoE primer sets are for expanding ApoE genetic fragments, and the rs429358 inner primers group is for amplification site containing rs429358 ApoE genetic fragments;The rs7412 inner primers group is used to expand the ApoE genetic fragments in the site containing rs7412.
3. a kind of ApoE gene detecting kits, which is characterized in that the ApoE gene detecting kits include claim 1 or ApoE genetic test primer sets described in 2.
4. ApoE gene detecting kits according to claim 3, which is characterized in that the ApoE gene detecting kits Further include connector, contain sequence label on the connector, the connector for directly with site containing rs429358 and/or rs7412 The amplified production connection in site.
5. ApoE gene detecting kits according to claim 3, which is characterized in that the ApoE gene detecting kits Rs429358 sequencing primers and/or rs7412 sequencing primers are further included, the rs429358 sequencing primers have SEQ ID NO: 29、SEQ ID NO:30、SEQ ID NO:31、SEQ ID NO:32、SEQ ID NO:33、SEQ ID NO:34 or SEQ ID NO:35 sequence;The rs7412 sequencing primers have SEQ ID NO:36、SEQ ID NO:37 or SEQ ID NO:38 sequence Row.
6. ApoE gene detecting kits according to claim 3, which is characterized in that the ApoE gene detecting kits Further include the oligonucleotide probe of unstressed configuration label.
7. a kind of ApoE gene testers, which is characterized in that include the following steps:
A, using rs429358 primer sets, the nucleic acid fragment in the site containing rs429358 is expanded, obtains rs429358 amplification productions Object;Or rs7412 primer sets are utilized, the nucleic acid fragment in the site containing rs7412 is expanded, obtains rs7412 amplified productions;
The rs429358 primer sets for expanding the nucleic acid fragment in the site containing rs429358, including rs429358 sense primers and Rs429358 downstream primers, the rs429358 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、 SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:11 sequence, the rs429358 downstream primers have SEQ ID NO:12、SEQ ID NO: 13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;
The rs7412 primer sets include rs7412 sense primers and rs7412 downstream primers, and the rs7412 sense primers have SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, it is described Rs7412 downstream primers have SEQ ID NO:12、SEQ ID NO:13 or SEQ ID NO:22 sequence;
B, the jointing on the rs429358 amplified productions and/or rs7412 amplified productions obtains rs429358 libraries point Son and/or rs7412 library molecules;
C, the library molecule is sequenced using second generation high throughput gene sequencing technology, determine rs429358 and/or The genotype in rs7412 sites.
8. ApoE gene testers according to claim 7, which is characterized in that the step A includes the following steps:
A1, ApoE genetic fragments are expanded using ApoE primer sets, obtains the first amplified production, the ApoE primer sets are included on ApoE Primer and ApoE downstream primers are swum, the ApoE sense primers have SEQ ID NO:1 or SEQ ID NO:2 sequence, it is described ApoE downstream primers have SEQ ID NO:12 or SEQ ID NO:13 sequence;
A2, using the first amplified production as template, using rs429358 inner primers group amplification the site containing rs429358 ApoE genes Segment, obtains the 2nd rs429358 amplified productions, the rs429358 inner primers group include in rs429358 sense primer and Downstream primer in rs429358, sense primer has SEQ ID NO in the rs429358:3、SEQ ID NO:4、SEQ ID NO:5 or SEQ ID NO:6 sequence, downstream primer has SEQ ID NO in the rs429358:14 or SEQ ID NO:15 Sequence;Or sense primer has SEQ ID NO in the rs429358:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10 or SEQ ID NO:Downstream primer has SEQ ID NO in 11, the rs429358:16、SEQ ID NO:17 or SEQ ID NO:18 sequence;Using the ApoE genetic fragments in rs7412 inner primers group amplification site containing rs7412, the 2nd rs7412 is obtained Amplified production, the rs7412 inner primers group include downstream primer in sense primer in rs7412 and rs7412, the rs7412 Interior sense primer has SEQ ID NO:19、SEQ ID NO:20 or SEQ ID NO:21 sequence, downstream in the rs7412 Primer has SEQ ID NO:22 sequence.
9. ApoE gene testers according to claim 8, which is characterized in that the step B includes the following steps:
B1, the jointing on the 2nd rs429358 amplified productions and/or the 2nd rs7412 amplified productions, obtain Rs429358 library molecules and/or rs7412 library molecules;
B2, by the biotin labeling on connector, the rs429358 library molecules and/or rs7412 library molecules are fixed on On magnetic bead containing Avidin;It is fixed on magnetic bead is addressable on solid phase carrier.
10. ApoE gene testers according to claim 7, which is characterized in that be sequenced in step C using rs429358 The library molecule containing site to be measured is sequenced in primer and/or rs7412 sequencing primers, the rs429358 sequencing primers tool There are SEQ ID NO:29、SEQ ID NO:30、SEQ ID NO:31、SEQ ID NO:32、SEQ ID NO:33、SEQ ID NO: 34 or SEQ ID NO:35 sequence;The rs7412 sequencing primers have SEQ ID NO:36、SEQ ID NO:37 or SEQ ID NO:38 sequence.
CN201611136848.2A 2016-12-12 2016-12-12 ApoE genetic tests primer sets, detection kit and detection method Pending CN108220414A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611136848.2A CN108220414A (en) 2016-12-12 2016-12-12 ApoE genetic tests primer sets, detection kit and detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611136848.2A CN108220414A (en) 2016-12-12 2016-12-12 ApoE genetic tests primer sets, detection kit and detection method

Publications (1)

Publication Number Publication Date
CN108220414A true CN108220414A (en) 2018-06-29

Family

ID=62637891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611136848.2A Pending CN108220414A (en) 2016-12-12 2016-12-12 ApoE genetic tests primer sets, detection kit and detection method

Country Status (1)

Country Link
CN (1) CN108220414A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029159A (en) * 2019-02-26 2019-07-19 成都华青精准医疗科技有限公司 A kind of nucleotide sequence group and its application for the detection of ApoE Genotyping

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105886607A (en) * 2015-12-22 2016-08-24 武汉康昕瑞基因健康科技有限公司 MTHFR gene detection method and kit
CN105886608A (en) * 2015-12-22 2016-08-24 武汉康昕瑞基因健康科技有限公司 ApoE gene primer group, detection kit and detection method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105886607A (en) * 2015-12-22 2016-08-24 武汉康昕瑞基因健康科技有限公司 MTHFR gene detection method and kit
CN105886608A (en) * 2015-12-22 2016-08-24 武汉康昕瑞基因健康科技有限公司 ApoE gene primer group, detection kit and detection method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029159A (en) * 2019-02-26 2019-07-19 成都华青精准医疗科技有限公司 A kind of nucleotide sequence group and its application for the detection of ApoE Genotyping

Similar Documents

Publication Publication Date Title
CN105886608B (en) ApoE gene primer group, detection kit and detection method
CN102329876B (en) Method for measuring nucleotide sequence of disease associated nucleic acid molecules in sample to be detected
CN110079592B (en) High throughput sequencing-targeted capture of target regions for detection of genetic mutations and known, unknown gene fusion types
CN103937896B (en) A kind of SNP classifying methods and kit
CN106554955B (en) Method and kit for constructing sequencing library of PKHD1 gene mutation and application thereof
CN105039322B (en) DNA sequence labels and sequencing library construction method and kit
CN112779320B (en) Multi-region DNA methylation detection probe design and detection method thereof
CN103131770B (en) The method that repetition DNA element predicts the efficiency that the target for next generation&#39;s sequencing is enriched with as negative control is used based on quantitative PCR
WO2009000912A2 (en) Fusion gene microarray
CN106701936A (en) Breast cancer susceptibility gene BRCA1 and BRCA2 detection kit and method
CN108690873A (en) The detection method and detection kit of 21 hydroxylase gene mutations
CN106591485B (en) A kind of Nucleic acid combinations and its application and kit detecting ALDH2 gene mutation
CN109161587A (en) A method of detection chromosome repeated fragment broken site and location information
CN106929507A (en) Primer sets, anchor primer, kit, library construction and gene order surveying method
CN108220414A (en) ApoE genetic tests primer sets, detection kit and detection method
CN107024583B (en) Thioflavine T aptamers, its screening technique and application
CN109439738A (en) ABCB1, CYP3A5 genetic test primer sets, kit and detection method
CN103981258B (en) A kind of tumor susceptibility gene SNP site detection method and kit
CN108220409A (en) Mthfr gene detection primer group, detection kit and detection method
CN115449540A (en) Detection method suitable for medium-flux nucleic acid space position information and application thereof
WO2022197801A1 (en) Systems and methods for determining barcodes and screening in situ
CN111718981A (en) ACE gene detection primer group, detection kit and detection method
CN112858693A (en) Biomolecule detection method
CN111718986A (en) PTGS1 gene detection primer group, detection kit and detection method
CN102010901B (en) Liquid phase chip and specific primer to test apo E gene and single nucleotide polymorphism (SNP) of 9p21 segment of chromosome

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180629